HWM
NKTR icon

HB Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

HB Wealth Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650K Buy
+9,315
New +$682K ﹤0.01% 975
2026
Q1 		– Sell
-9,244
Closed -$391K – 1579
2025
Q4 		$391K Hold
9,244
– – ﹤0.01% 1004
2025
Q3 		$526K Buy
+9,244
New +$306K ﹤0.01% 834
2025
Q2 		– Sell
-5,274
Closed -$53.8K – 1255
2025
Q1 		$53.8K Buy
5,274
+1,001
+23% +$13.1K ﹤0.01% 1192
2024
Q4 		$60.4K Buy
4,273
+1,306
+44% +$23K ﹤0.01% 1043
2024
Q3 		$57.9K Buy
+2,967
New +$56.6K ﹤0.01% 947

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HB Wealth Management's NKTR Position: Q2 2026 in Review

HB Wealth Management opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 9,315 shares worth $650K. The stake represents ﹤0.01% of the portfolio and ranks #975 among its holdings. This is a return to the name: HB Wealth Management previously reported a position in NKTR as recently as Q4 2025.

HB Wealth Management first reported a position in NKTR in Q3 2024 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • HB Wealth Management held 9,315 shares of Nektar Therapeutics worth $650K as of Q2 2026.
  • Nektar Therapeutics was a new HB Wealth Management position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #975 holding.
  • HB Wealth Management first reported a position in Nektar Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.